Mental Health Program for Young Adults

N/A

Waitlist Available

Research Sponsored by New York University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 18-34

Be between 18 and 65 years old

Must not have

Cognitive impairments (i.e., young adult cannot understand consent process)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline through study completion, an average of 2 years; repeated measure to assess change through study completion

Awards & highlights

No Placebo-Only Group

Summary

This trial tests a culturally-responsive mental health program called 'Just Do You' for young adults from minority groups. It includes new parts that use cultural interviews and creative arts to better connect with participants. The goal is to help them stay involved in their treatment and use mental health services more effectively.

Who is the study for?

This trial is for racial and ethnic minority young adults experiencing conditions like psychosis, bipolar disorder, or depression. It's designed to help them engage with mental health services through a new program.

What is being tested?

The study tests a culturally-responsive orientation program called 'Just Do You,' which includes various components (A, B, C) aimed at improving engagement in community mental health services over a 24-month period.

What are the potential side effects?

Since this is not a drug trial but an engagement program for mental health services, traditional side effects are not applicable. However, participants may experience emotional discomfort or stress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 34 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I understand the consent process.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline through study completion, an average of 2 years; repeated measure to assess change through study completion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline through study completion, an average of 2 years; repeated measure to assess change through study completion

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through study completion, an average of 2 years; repeated measure to assess change through study completion for reporting.